
Ixoglime GM 2 Tablet ER
Marketer
Unique Life Sciences (P) Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Ixoglime GM 2 Tablet ER
Glycemic control in adults with type 2 diabetes mellitus is achieved with the dual-action antidiabetic medication, Ixoglime GM 2 Extended-Release Tablets. This formulation combines two active ingredients to manage blood glucose. Optimal efficacy requires consistent daily dosing at the same time, always taken with food. Dosage adjustments are determined by your physician based on individual blood sugar monitoring. Continuous use, even with well-controlled glucose, is crucial. Discontinuation without medical supervision may lead to elevated blood sugar, potentially resulting in complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember that this medication complements, not replaces, a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Learn to recognize its symptoms – sweating, dizziness, headache, and tremors – and have a readily available fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be minimized. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal pain, cephalalgia, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess hematological parameters and liver function, are essential.
Primary Ingredients of Ixoglime GM 2 Tablet ER
No text provided. Please provide the text you would like me to rephrase.
Uses of Ixoglime GM 2 Tablet ER
Managing type 2 diabetes
Major Benefits of Ixoglime GM 2 Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ixoglime GM 2 Extended-Release tablets should be administered with a meal.
Common Side effects of Ixoglime GM 2 Tablet ER:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Ixoglime GM 2 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ixoglime GM 2 Extended-Release Tablets should be taken with a meal.
How Ixoglime GM 2 Tablet ER works:
Ixoglime GM 2 Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Ixoglime GM 2 Tablet ER and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Ixoglime GM 2 Tablet ER during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Ixoglime GM 2 tablets are contraindicated for breastfeeding mothers due to the potential for infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Ixoglime GM 2 Tablet ER cautiously, potentially requiring dosage modification. Consult a physician for guidance. Ixoglime GM 2 Tablet ER is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
The extended-release Ixoglime GM 2 Tablet requires careful administration in individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver dysfunction, a low initial dose of Ixoglime GM 2 Tablet ER is typically prescribed; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Ixoglime GM 2 Tablet ER :
Should you forget a dose of Ixoglime GM 2 Tablet ER, take it immediately if you remember. However, near the time for your next dose, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ixoglime GM 2 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
